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Summary Serum vitamin A and its carrier proteins, retinol-binding
protein and prealbumin, were measured in 41 colorectal cancer patients,
40 patients with benign colorectal disease, and 31 healthy subjects. Serum
samples were obtained from the Mayo Clinic (NCI-Serum diagnostic
Bank, Rochester, MN), The values for each of the three parameters were
significantly lower in colorectal cancer patients than in healthy subjects
but were litte1e different from the val ues seen in patients with benign
disease.
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There is considerable evidence from case-control studies that a low serum
level of vitamin A is an important risk factor for the development of a variety of
human cancers of epithelial cell origin [1-8]. Several of these studies [1,4-6, 8J
have aiso indicated that the presence of an established cancer is associated with
low serum concentrations of the vitamin A transport proteins, which include
retinol-binding protein (RBP) and prealbumin. Furthermore, in our recent study
[9] where serum vitamin A and RBP levels were measured in patients with
surgical1y resected cancers of the colon and rectum, those who subsequently had
recurrent disease showed lower levels of vitamin A and RBP compared with those
who remained free of recurrence. Low RBP levels in plasma have also been
reported in patients with recurrence of breast tumors, when compared with the
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levels in breast cancer patients who remained disease-free fonowing mastectomy
and adjuvant chemotherapy
~ la, 11].
We present here the results of a case-control study in which serum vitamin A
and its transport proteins were measured in patients with malignant and non-
malignam colorectal disease as well as in age- and sex-matched healthy subjects.
The biochemical evidence of a low vitamin A level appeared to be a common
factor for both benign and malignant colorectal disease.
SUBJECTS AND METHODS
A total of Ii 2 subjects including 41 colorectal cancer patients with distal
metastases without liver involvement, 40 patients with benign co!orectal disease
induding polyps, inflammatory bowel disease, and diverticulitis, and 31 healthy
subjects were studied. The particulars of th~se subjects are shown in Table 1.
Serum samples from these subjects were obtained from the Mayo Clinic (NCI-
Serum Diagnostic Bank), Rochester, MN. The identity of cases and controls was
not revealed to us until the data were sent to the Information Management Services
(IMS) Data Center, Silver Spring, MD, for analysis.
Vitamin A was determined in the sera by a modification [12] of the fluoro-
metric method of Hansen and \Varwick [13]. RBP and prealbumin were deter-
mined by the single radial immunodiffusion technique [14] using LC-partigen
immunodiffusion plates (Behring Diagnostic, Marburg, FRG). The data were
analyzed statistically by Spearman rank correlation, the Kruskal-Wallis test, and
the Wilcoxon rank sum.
RESUL TS
No significant differences due to sex were found in the median assay values fOT
vitamin A, RBP, or prealbumin in any of the three groups of subjects. However,
in the group as a whole, prealbumin was higher in males an this achieved marginal
significance (p<O.05). The Spearman rank correlations showed that age is not
significantly correlated with assay values in any of the three groups of subjects. In
the groups combined, prealbumin was significantly correlated with age (r= -0.22;
p < 0.02).
The values for the three study parameters in the three groups of subjects are
Table 1. Particulars of the subjects studied.
Colorectal cancer
Benign colorectal disease
Healthy
41
40
31
19
1]
13
22
29
18
Age (years)
(Mean with median
in parenthesis)
59.8 (62.0)
56.0 (57.5)
57.0 (59.0)
Subject Tota!
number
Sex
Male Female
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Colorectal Benign Healthy Overall Comparison
cancer colorectal subjects Kruskal- Wallis colorectalMeasurement (n=14) (n=40) (n=3l) vs. normaltest
Mean SD Mean SD Mean SD (p-value) (p-value)
Vitamin A 83.3 3R.7 80.9 29.8 128.9 50.2 0.000] < 0.0001
(ug/dl)
RBP 4.28 1.72 3.94 1.27 5.06 1.37 0.003 0.01
(mg/dl)
Prealbumin 26.7 9.2 28.6 8.7 34.1 6.3 0.0003 0.0001
(mg/d!)
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Table 2. Serum vitamin A, R BP, and prealbumin jn patients with colorectal cancer or
benign colorectal disease and in healthy subjects.
Table 3, Correlations between assay measurements.
Spearman
correlation
coefficient
p-value
All patients (n = 112)
Vitamin A with REP
Vitamin A with prea1bumin
RBP with prealbumin
Colorectal (n=41)
Vitamin A with RBP
Vitamin A with prealbumin
RBP with prealbumin
Benign GI (n=40)
Vitamin A with RBP
Vitamin A with prealbumin
RBP with prealbumin
Normals (n=31)
Vitamin A with RBP
Vitamin A with prealbumin
RBP with prealbumin
0.72
0.69
0.87
<0.0001
<0.000]
<0.000]
0.72
0.76
0.86
<0.0001
<0.0001
< 0,000 I
0.76
0.74
0.91
0.0001
0.000]
0.0001
0.49
0.36
0.77
0.005
0.05
0.0001
shown in Table 2. Pair-wise comparisons showed that for each study parameter,
values for colorectal cancer subjects were significantly lower than those for healthy
subjects but were not significantly different from those for the subjects with benign
colorectal disease. The correlations between assay measurements were found to be
highly significant (Table 3).
DISCUSSlON
There have been many case-control studies showing an inverse relationship
between cancer incidence and serum concentrations of vitamin A [6, 8, 9, 15, 16].
AU of these studjes have shown subnormal levels of serum vitamin A in cancer
patients compared with the levels of healthy subjects or patients with unspecified
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non-malignant disease. These findings are similar to the results obtained in the
present study. Not only the serum levels of vitamin A but also of its transport
proteins (RBP and prealbumin) were significantly lower in patients with colorectal
cancer than in age- and sex-matched healthy subjects. However, no significant
differences were apparent when the colorectal cancer patients were compared with
a different control group, namely, subjects with benjgn coJorectal disease. These
results indicate thm depressed levels of the three study parameters are a feature of
a diseased state and are not specific to cancer. The results therefore provide no
evidence that abnormalities of vitamin A status are directly related to cancer (c.g.,
by being a precursor or a consequence).
Vitamin A in the serum was measured by the fluorometric procedure of
Hansen and 'Warwick [13J, which has been reported to measure not only vitamin
A hut also phytofl uene, a non-vitamin A component [17]. Hence, it may be argued
that the validity of the conclusions based on the serum vitamin A levels is
questionable. It should, however, be pointed out that serum vitamin A determined
in this study was highly correlated with RBP and prealbumin. Thus values derived
by simple fluorometry do, at least in part, reflect serum vitamin A. Furthermore,
measurement of senlm vitamin A alone, even by the most specific method, provides
little information on the cause of the low levels because serum vitamin A concen-
trations are nOT generally strongly influenced by dietary vitamin A intake [18J.
It is noteworthy rhat the results of the present study resemble a similar study
carried out on breast cancer [19]. In that study also cancer patients had lower
serum values for the three parameters sludied here but the magnitude of the
differences were reduced when the cancer patients were compared with patients
suffering from benign breast disease. These resulrs underline the importance of the
use of appropriate controls; had we used only healthy subjects as the control
group, we would have drawn erroneous conel usions.
A low serum vitamin A concentration may occur in true vitamin A deficiency
or in conditions in which there is low mobilization from liver stores such as stress
[20J, infections [2JJ, protein-energy malnutrition [22J. and low zinc status [23].
For instance, in patients with protein-energy malnutrition, serum concentrations
of both RBP and prealbumin are reduced; while administration of protein without
v'itamin A causes a rise in serum vitamin A and its carrier proteins levels in these
patients [24]. It seems importam that the factors affecting vitamin A utilization
should be controlled by LIse of an appropriate 'control' population, especial1y in
case-control studies. For cancer patients, such 'control' subjects should be those
with benign disease affecting the same site as in the malignant patients. This is
especiaJIyimportant when patients with gastrointestinal cancer are studied.
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